Lymphoma Leukemia & Myeloma 2020 Virtual Congress

Recognized as one of the most respected forums for industry-leading hematologic research and clinical case studies, the Lymphoma, Leukemia and Myeloma Congress is the meeting where interdisciplinary specialists convene to explore the controversial and complex world of blood cancer through debate, discussion and networking. The 20th anniversary of the meeting will be held virtually October 21-24, and will feature a Non-Malignant Hematology Pre-Conference Workshop on October 20. You can earn 30+ CME credits from the comfort of your home or office when you participate in the virtual event. Learn more and register here.

NCCN Recommends Zanubrutinib as First-Line, Second-Line Therapy in CLL/SLL
January 4, 2021

Update on CALAVI Phase II trials for Acalabrutinib in Patients Hospitalized with Respiratory Symptoms of COVID-19
January 4, 2021

CLL Society’s Official Statement Concerning SARS-CoV-2 Vaccine in CLL Patients 1/04/2021
January 4, 2021

Do I need a Pulse Oximeter?
December 4, 2020

Dr. Koffman on COVID-19 Vaccines
November 30, 2020

Ascentage Pharma Announces First Patient Dosed in Europe in the Phase Ib/II Study of the Bcl-2 inhibitor APG-2575 in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
November 25, 2020